Long Beach Clinical Trials, LLC

Long Beach, California 90806

0 studies enrolling now · 8 studies all time

What they study most

Bacterial Infections, COVID-19, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Overactive Bladder, Peanut Allergy, Viral Respiratory Illnesses

Studies at this site

• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection — Completed
• CNP-201 in Subjects With Peanut Allergy — Stopped early
• A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19 — Stopped early
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness — Completed
• An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• Study of Debio 1450 for Bacterial Skin Infections — Completed